These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1959 related articles for article (PubMed ID: 25233993)

  • 1. mRNA-based therapeutics--developing a new class of drugs.
    Sahin U; Karikó K; Türeci Ö
    Nat Rev Drug Discov; 2014 Oct; 13(10):759-80. PubMed ID: 25233993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA transcript therapy.
    Weissman D
    Expert Rev Vaccines; 2015 Feb; 14(2):265-81. PubMed ID: 25359562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic mRNA delivery to leukocytes.
    Granot-Matok Y; Kon E; Dammes N; Mechtinger G; Peer D
    J Control Release; 2019 Jul; 305():165-175. PubMed ID: 31121277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges.
    Steinle H; Behring A; Schlensak C; Wendel HP; Avci-Adali M
    Stem Cells; 2017 Jan; 35(1):68-79. PubMed ID: 27250673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of rational design of mRNA-based therapeutics and vaccines.
    To KKW; Cho WCS
    Expert Opin Drug Discov; 2021 Nov; 16(11):1307-1317. PubMed ID: 34058918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo.
    Rybakova Y; Kowalski PS; Huang Y; Gonzalez JT; Heartlein MW; DeRosa F; Delcassian D; Anderson DG
    Mol Ther; 2019 Aug; 27(8):1415-1423. PubMed ID: 31160223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration.
    Johler SM; Rejman J; Guan S; Rosenecker J
    PLoS One; 2015; 10(9):e0137504. PubMed ID: 26352268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.
    Guan S; Rosenecker J
    Gene Ther; 2017 Mar; 24(3):133-143. PubMed ID: 28094775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA-based therapies: Preclinical and clinical applications.
    Qureischi M; Mohr J; Arellano-Viera E; Knudsen SE; Vohidov F; Garitano-Trojaola A
    Int Rev Cell Mol Biol; 2022; 372():1-54. PubMed ID: 36064262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IVT-mRNA reprogramming of myeloid cells for cancer immunotherapy.
    Jolly KJ; Zhang F
    Adv Pharmacol; 2024; 100():247-288. PubMed ID: 39034054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Materials for non-viral intracellular delivery of messenger RNA therapeutics.
    Kauffman KJ; Webber MJ; Anderson DG
    J Control Release; 2016 Oct; 240():227-234. PubMed ID: 26718856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.
    Sahu I; Haque AKMA; Weidensee B; Weinmann P; Kormann MSD
    Mol Ther; 2019 Apr; 27(4):803-823. PubMed ID: 30905577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA-Based Therapeutics in Cancer Treatment.
    Sun H; Zhang Y; Wang G; Yang W; Xu Y
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of synthetic mRNAs for tissue regeneration.
    Steinle H; Weber J; Stoppelkamp S; Große-Berkenbusch K; Golombek S; Weber M; Canak-Ipek T; Trenz SM; Schlensak C; Avci-Adali M
    Adv Drug Deliv Rev; 2021 Dec; 179():114007. PubMed ID: 34710530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in mRNA non-viral delivery approaches.
    Ibba ML; Ciccone G; Esposito CL; Catuogno S; Giangrande PH
    Adv Drug Deliv Rev; 2021 Oct; 177():113930. PubMed ID: 34403751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape.
    Miliotou AN; Georgiou-Siafis SK; Ntenti C; Pappas IS; Papadopoulou LC
    Curr Issues Mol Biol; 2023 Nov; 45(11):9181-9214. PubMed ID: 37998753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine.
    Kwon H; Kim M; Seo Y; Moon YS; Lee HJ; Lee K; Lee H
    Biomaterials; 2018 Feb; 156():172-193. PubMed ID: 29197748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.
    Kang DD; Li H; Dong Y
    Adv Drug Deliv Rev; 2023 Aug; 199():114961. PubMed ID: 37321375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA therapeutics for disease therapy: principles, delivery, and clinical translation.
    Zhou DW; Wang K; Zhang YA; Ma K; Yang XC; Li ZY; Yu SS; Chen KZ; Qiao SL
    J Mater Chem B; 2023 Apr; 11(16):3484-3510. PubMed ID: 36988384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine-Based Approaches for mRNA Delivery.
    Uchida S; Perche F; Pichon C; Cabral H
    Mol Pharm; 2020 Oct; 17(10):3654-3684. PubMed ID: 32845639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.